Towa Pharmaceutical Co., Ltd. (4553.T) JPX

Currency In JPY

AD

Valuation

Market Cap197.16B
Enterprise Value378.59B
P/E Ratio36.05
PEG Ratio-0.5
Price/Sales Ratio0.69
Price/Book Ratio1.06
Enterprise/Revenue1.35
Enterprise/EBITDA9.69

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue273.71B
Revenue/Share5,560.05
Gross Profit99.1B
EBITDA38.26B
Net Income5.25B
Diluted EPS106.65

Balance Sheet

Total Cash45.31B
Total Cash/Share920.33
Total Debt226.74B
Total Debt/Equity1.27
Current Ratio2.76
Book Value Per Share3,618.02

Price History

52-Week Change31.81
52-Week High4,490
52-Week Low2,764
Moving Average 50 Days3,893
Moving Average 200 Days3,591.37

Statistics

Average Volume132,398
Shares Outstanding49.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate80
Trailing Annual Dividend Yield2.08
Payout Ratio0.75
Last Split Factor3:1
Last Split DateMarch 27, 2019
AD